Connect with Solentim at IMAPAC: Biologics World Nordic 2019
Solentim, a global leader in cell line development instrumentation, will be attending IMAPAC’s Biologics World Nordic event, 5-7 March in Stockholm. Experts from the Company will be on hand throughout the event at the Solentim exhibition booth (number 2) to discuss our latest innovations and to answer any questions.
The global biologic medicines market is expanding rapidly in both size and geography and is projected to exceed USD390 billion by 2020, by which time biologics will account for up to 28% by value of the global market for pharmaceuticals. Biologics World Nordic 2019 will focus on R&D, process development and manufacturing within this industry, showcasing the Nordic biologics industry as an innovation hub globally, and facilitating partnerships and collaborations with biopharma from across the world.
Dr Ian Taylor, Chief Commercial Officer for Solentim, commented: “As a global company, working with most of the world’s Top-10 pharmaceutical companies and a majority of the world’s leading biotech companies we have staff, customers and collaborators based around the world. We are excited to return to Biologics World Nordic 2019 for the second year running to further solidify our networks in this region, and to meet new customers and collaborators.”
Solentim will be at booth 2 throughout the event – please do come and say hi, or get in touch to arrange a meeting.